QIF-T0141
highMagnetothermal nanoparticle TRPV1 stimulation (AMF)
Tier 3 — Demonstrated (Lab-proven)
Legacy status: DEMONSTRATED
Technique Details
- Tactic
- QIF-E.RD
- Status
- DEMONSTRATED
- Bands
- I0, N1, N2, N3
✚ Therapeutic Application
Alternating magnetic field (160-570 kHz, NOT optical) drives hysteretic heating of injected iron-oxide or ferrite nanoparticles. Local temperature rise >43.8C activates TRPV1 channels. Reversed Parkinson's symptoms in MPTP/6-OHDA mice. WARNING: iron-oxide NPs in VTA/SNc add exogenous iron to brain regions where Fenton chemistry is a neurotoxicity risk. 10ug/ml ferric oxide depleted cellular DA by 68% in 24hrs (Imam 2015).
Clinical Analog
Magnetothermal deep brain stimulation for Parkinson's
Treats
- Parkinson's disease
Neural Impact
4 of 7 neural bands affected
Drag to rotate. Click a region to learn more.
Click or hover over a glowing region to see the attack techniques targeting it and their severity.
Scoring
Validation Status
Theoretical / Not yet validated. This technique has not been independently tested. See the validation dashboard for what has been tested.